Correction to: Augmentation of tumor expression of HLADR, CXCL9, and CXCL10 may improve olfactory neuroblastoma immunotherapeutic responses

• Riley M. Larkin,
• Diana C. Lopez,
• Yvette L. Robbins,
• Wiem Lassoued,
• Kenneth Canubas,
• Andrew Warner,
• Baktiar Karim,
• Ksenia Vulikh,
• James W. Hodge,
• Charalampos S. Floudas,
• James L. Gulley,
• Gary L. Gallia,
• Clint T. Allen,
• Nyall R. London

Affiliations

Riley M. Larkin

Sinonasal and Skull Base Tumor Program, Surgical Oncology Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health

Diana C. Lopez

Sinonasal and Skull Base Tumor Program, Surgical Oncology Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health

Yvette L. Robbins

Section on Translational Tumor Immunology, Center for Cancer Research, National Cancer Institute, National Institutes of Health

Wiem Lassoued

Center for Immuno-Oncology, Center for Cancer Research, National Cancer Institute, National Institutes of Health

Kenneth Canubas

Center for Immuno-Oncology, Center for Cancer Research, National Cancer Institute, National Institutes of Health

Andrew Warner

Molecular Histopathology Laboratory, Frederick National Laboratory for Cancer Research

Baktiar Karim

Molecular Histopathology Laboratory, Frederick National Laboratory for Cancer Research

Ksenia Vulikh

Molecular Histopathology Laboratory, Frederick National Laboratory for Cancer Research

James W. Hodge

Center for Immuno-Oncology, Center for Cancer Research, National Cancer Institute, National Institutes of Health

Charalampos S. Floudas

Center for Immuno-Oncology, Center for Cancer Research, National Cancer Institute, National Institutes of Health

James L. Gulley

Center for Immuno-Oncology, Center for Cancer Research, National Cancer Institute, National Institutes of Health

Gary L. Gallia

Department of Otolaryngology-Head and Neck Surgery, Johns Hopkins University School of Medicine

Clint T. Allen

Section on Translational Tumor Immunology, Center for Cancer Research, National Cancer Institute, National Institutes of Health

Nyall R. London

Sinonasal and Skull Base Tumor Program, Surgical Oncology Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health